Vipoglanstat has reached the halfway point for patient recruitment in a phase 2 endometriosis trial. Gesynta Pharma said 50 per...
By Dr Caitlin Hall, chief dietitian and head of clinical research at myota
The developers say the device could provide an alternative diagnostic test to the Pap smear
As the endometriosis market is expected to reach US$3.2bn by 2030, we take a closer look at four start-ups in this sector
By Cindy Moy Carr, founder and CEO of Vorsdatter Limited
Dr Karla Loken, a board-certified OBGYN, will be tasked with helping the company meet its objectives for 2023
On January 24, the UK government rejected recommendations from the Women and Equalities Committee to trial menopause leave pilots. It also dismissed recommendations to make menopause...
The primary care clinic will be offering memberships to employers to provide accessible virtual care
Research shows new mothers across the MENA region are still experiencing high levels of anxiety and depression
TBD Health aims to empower users to get tested and reduce the stigma around sexual health
The company aims to reverse the rise of late-stage cervical cancer and get women up to date on their screenings
Villalba brings more than 30 years of industry experience in developing and commercialising innovative products and therapies
By Kate Newhouse, COO at the online mental health platform Kooth Digital Health
The patent encompasses a system that measures follicle-stimulating hormones, oestrogen, LH, and progesterone markers
By Dr Shahzadi Harper, menopause specialist and GP
This week we meet Jyoti Sharma, founder and CEO of TaraCares
Stigma and misinformation are putting women off attending smear tests and essential checks, research reveals
The partnership aims to serve more than 100,000 women in the next five years
HBMAT's programmes aim to deliver precision therapies for endocrine disorders
By Emma-Louise Fusari, founder of In-House Health
With 57 per of the app's active users female, tags like #IVF or #infertility have amassed billions of views
